GS
EW icon

Girard Securities’s Edwards Lifesciences EW Stock Holding History

Girard Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,150
Closed -$225K – 30
2017
Q3 		$225K Sell
6,150
-1,245
-17% -$47.5K 0.2% 113
2017
Q2 		$292K Sell
7,395
-75
-1% -$2.74K 0.22% 112
2017
Q1 		$234K Sell
7,470
-1,470
-16% -$46K 0.2% 130
2016
Q4 		$279K Hold
8,940
– – 0.24% 119
2016
Q3 		$359K Sell
8,940
-2,700
-23% -$102K 0.37% 78
2016
Q2 		$388K Buy
11,640
+150
+1% +$5.13K 0.36% 86
2016
Q1 		$338K Sell
11,490
-1,200
-9% -$33.1K 0.33% 91
2015
Q4 		$336K Buy
+12,690
New +$330K 0.34% 95

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Girard Securities's EW Position: Q4 2017 in Review

Girard Securities sold out of Edwards Lifesciences (EW) in Q4 2017, closing a stake of 6,150 shares — an estimated $225K sold.

Girard Securities first reported a position in EW in Q4 2015 and held it in 8 quarters. The position peaked at $388K in Q2 2016. 772 funds tracked by Wall St. Rank hold EW as of Q4 2017.

  • Girard Securities reported no remaining Edwards Lifesciences position as of Q4 2017 after selling out during the quarter.
  • Girard Securities sold 6,150 Edwards Lifesciences shares in Q4 2017, an estimated $225K.
  • Girard Securities first reported a position in Edwards Lifesciences in Q4 2015 and held it in 8 quarters.
  • Girard Securities's Edwards Lifesciences position peaked at $388K in Q2 2016.
  • 772 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2017.

Based on Girard Securities's 13F filing for Q4 2017.